oncology
1,857 projects
breast cancer168leukemia137skin cancer106prostate cancer99colorectal cancer78lung cancer67pancreatic cancer42liver cancer37cervical cancer10bladder cancer10head and neck cancer7
FP7Reintegration grant2011–2013United Kingdom
pARylome · pARylation-mediated regulation of cancer pathways
FP7Individual fellowship2011–2015Hungary
CB1R ARRESTIN · Contribution of beta-arrestin-dependent receptor signaling to the physiological regulation of the endocannabinoid system
FP7Individual fellowship2011–2012United Kingdom
PI3K SYSTEMS BIOLOGY · In-depth quantification and characterisation of PI 3-kinase signalling networks at a System Biology level
FP7Individual fellowship2011–2012Greece
CHROMOREPAIR · Deciphering the role of chromatin remodelling in DNA damage repair
FP7Individual fellowship2011–2012United Kingdom
CHROMALC1HCC · “The role of ALC1, a novel ATP-dependent chromatin remodelling protein, in transcriptional regulation, tumorigenesis and neurodegeneration”
FP7Individual fellowship2011–2012United Kingdom
RAS AND MMP7 · Investigation of a dependency of RAS-driven cancers on matrix metalloproteinase-7
FP7Reintegration grant2011–2014Germany
MORPHOGENESIS · Coordinating cell differentiation and morphogenesis in a migrating tissue
FP7Individual fellowship2011–2013United Kingdom
WNT VASCULAR REMODEL · Molecular control of vascular remodelling: A role for Wnt signalling.
FP7Reintegration grant2010–2014United Kingdom
SUGABACT · THE ROLE OF O-GlcNAc IN BACTERIAL SIGNAL TRANSDUCTION AND VIRULENCE
FP7Individual fellowship2010–2015Italy
TIGRE · Targeting glucocorticoid resistance in T-ALL: a Systems Biology approach
FP7Individual fellowship2010–2012France
APL · ANALYSIS OF PML/RARA ONCOGENIC COMPLEX IN ACUTE PROMYELOCYTIC LEUKEMIA
FP7Staff exchange2010–2014United Kingdom
MEAD-ET · Novel medical adsorbents for extracorporeal treatment of life threatening conditions
2 partners · 2 countries
FP7Reintegration grant2010–2014Israel
RISK-UPDATE · Identification of the process by which patients recall and UPDATE their subjective RISK assessments for various diseases to incorporate objective genetic risk information
FP7Reintegration grant2010–2014Czechia
GCPII_SYSTEM · Design and development of novel reagents, tools, and techniques targeting human glutamate carboxypeptidases II and III
FP7Individual fellowship2010–2013Ireland
INKT CELLS · Omental iNKT cells as an Immunological Tools in Obesity and Cancer
FP7Individual fellowship2010–2013United Kingdom
HSCS AND HIF · The role of hypoxia-inducible factors in human haematopoietic stem cell biology and leukaemogenesis
FP7Individual fellowship2010–2012Germany
SURFACE ENDOCYTOSIS · Effect of nano-patterned substrate properties on cell attachment and endocytosis
FP7Reintegration grant2010–2014Germany
GAMNG · Identification of the genetic and/or epigenetic events that lead to mesenchymal transformation in glioblastoma
FP7Individual fellowship2010–2013Spain
PC INTERACTOME · Assembly of a prostate cancer genome-wide molecular interactome for the identification of the key regulatory genes of malignant transformation and new targets for therapeutic intervention
FP7Reintegration grant2010–2014Israel
METASTASIS SYS MOD · System level modelling of metastasis from signalling to cell motility
FP7Reintegration grant2010–2014Germany
LEUKEMOGENESISAPL · An in-vivo Screen for the Identification of Leukemia-Promoting Factors
FP7Staff exchange2010–2014Ireland
BIOMARKERIGF · Identification of Clinically Useful Biomarkers for IGF-I Receptor Signalling n Cancer
2 partners · 2 countries
FP7Individual fellowship2010–2012United Kingdom
IFIMAP · Investigating the Functional Implications of MICA Polymorphisms
FP7Individual fellowship2010–2012United Kingdom